HOSPITAL PRODUCTS IN VERSICOR TERRITORY AND BIOSEARCH TERRITORY Sample Clauses

HOSPITAL PRODUCTS IN VERSICOR TERRITORY AND BIOSEARCH TERRITORY. (a) CO-DEVELOPMENT. In the event the Parties determine to pursue additional preclinical and clinical testing of a Hospital Product for the same indication and in reasonably similar time frames, the Parties shall co-develop such Hospital Product to the extent feasible. In such event, the Parties shall share equally all costs associated with any preclinical studies required for the filing of an IND in both the Biosearch Territory and the Versicor Territory, as well as all costs associated with the conduct of all human clinical trials needed to compile the Core Dossier. Each Party shall be responsible for all costs associated with any other human clinical trials that are incremental to those in the Core Dossier and required for regulatory approval only in the Biosearch Territory, in the case of Biosearch, or in the Versicor Territory, in the case of Versicor. The Parties shall jointly own all data in the Core Dossier.
Sample 1Sample 2
AutoNDA by SimpleDocs

Related to HOSPITAL PRODUCTS IN VERSICOR TERRITORY AND BIOSEARCH TERRITORY

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Territory The territorial limits of this Agreement shall be identical with those of the Reinsured Contracts.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Product The term “

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!